Cardiac functional reserve is diminished in growth hormone-deficient adults

Cardiovascular Therapeutics

Volumn 27, Issue 1, 2009, Pages 34-41

  Moisey, Robert ^a   Orme, Steve ^a   Barker, Diane ^a   Lewis, Nigel ^a   Sharp, Lisa ^b   Clements, Richard E ^b   Goldspink, David F ^b   Tan, Lip Bun ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Aerobic capacity; Cardiac function; Chronotropic incompetence; Growth hormone deficiency; Peak cardiac power

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT GLUCAGON; SOMATOMEDIN C;

ADULT; AEROBIC CAPACITY; ARTICLE; BODY COMPOSITION; BODY SIZE; CHRONOTROPISM; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TEST; FEMALE; FITNESS; GROWTH HORMONE DEFICIENCY; HEART FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE PRESSURE; HEMODYNAMICS; HORMONAL THERAPY; HUMAN; HYPOPITUITARISM; MALE; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ABSORPTIOMETRY, PHOTON; ADULT; BLOOD PRESSURE; BODY SIZE; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OXYGEN CONSUMPTION; RECOMBINANT PROTEINS; VASCULAR RESISTANCE;

EID: 60349089114     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00073.x     Document Type: Article

References (40)

1. Jorgensen JOL, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansens T, Skakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989 1 : 1221 1225.
2. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 336 : 285 288.
3. Cittadini A, Cuocolo A, Merola B, Fazio S, Sabatini D, Nicolai E, Colao A, Longobardi S, Lombardi G, Sacca L. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol 1994 267 : E219 E225.
4. Colao A, Di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: A 12-month prospective study. J Clin Endocrinol Metab 2002 87 : 1088 1093.
5. Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 2001 86 : 1874 1881.
6. Colao A, Di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G. The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study. J Clin Endocrinol Metab 2004 89 : 5998 6004.
7. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA. Myocardial dysfunction in treated adult hypopituitarism: A possible explanation for increased cardiovascular mortality. Br Heart J 1992 67 : 92 96.
8. Thuesen L, Jorgensen JOL, Muller JR, Kristensen BØ, Skakkebaek NE, Vahl N, Christiansen JS. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol 2004 41 : 615 620.
9. Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, et al. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. J Clin Endocrinol Metab 2000 85 : 3762 3769.
10. Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency. Clin Endocrinol 2004 61 : 113 122.
11. Gibney J, Walllace J, Spinks DT, Schnorr L, Ranicar A, Cuneo RC, Lockhart S, Burnand KG, Saloman F, Sonksen PH, Russell-Jones D. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol Metab 1999 84 : 2596 2602.
12. Rodriguez-Arnao J, Jabbar A, Fulcher K, Besser GM, Ross RJM. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults. Clin Endocrinol 1999 51 : 53 60.
13. Chantler PD, Clements RE, Sharp L, George KP, Tan LB, Goldspink DF. The influence of body size on measurements of overall cardiac function. Am J Physiol Heart Circ Physiol 2005 289 : 2059 2065.
14. Cooke GA, Marshall P, Al-Timman JK, Wright DJ, Riley R, Hainsworth R, Tan LB. Physiological cardiac reserve: Development of a non-invasive method and first estimates in man. Heart 1998 79 : 289 294.
15. Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet 1986 328 : 1360 1363.
16. Chantler PD, Goldspink DF, Clements RE, Sharp L, Schlosshan D, Tan LB. Congestive heart failure: Extent of cardiac functional changes due to aging and organ dysfunction. Heart 2006 92 : 686 688.
17. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003 18 : 215 222.
18. Schlosshan D, Barker D, Pepper C, Williams G, Morley C, Tan LB. Cardiac resynchronization therapy improves the exercise capacity and functional reserve of the failing heart through enhancing the cardiac flow- and pressure-generating capacity. Eur J Heart Fail 2006 8 : 515 521.
19. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P, Tan LB. Peak exercise cardiac power output: A direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001 22 : 1496 1503.
20. National Institute of Clinical Excellence. Technology appraisal 64. Human growth hormone (somatropin) in adults with growth hormone deficiency. London : National Institute for Clinical Excellence, 2003 ISBN: 1-84257-356-X.
21. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916 17 : 863 871.
22. 2 tensions by rebreathing. J Appl Physiol 1956 9 : 25 29.
23. Vanhees L, Defoor J, Schepers D, Brusselle S, Reybrouck T, Fagard R. Comparison of cardiac output measured by two automated methods of CO2 rebreathing. Med Sci Sports Exerc 2000 32 : 1028 1034.
24. 2 rise during rebreathing. J Appl Physiol 1958 13 : 159 164.
25. Meaney E, Alva F, Moguel R, Meaney A, Alva J, Webel R. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart 2000 84 : 64.
26. Longobardi S, Cuocolo A, Merola B, Di Rella F, Colao A, Nicolai E, Cardei S, Salvatore M, Lombardi GL. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol 1998 48 : 137 143.
27. Climent VE, Picó A, Sogorb F, Aznar S, Lip GY, Marín F. Growth hormone therapy and the heart. Am J Cardiol 2006 97 : 1097 1102.
28. Cuocolo A, Nicolai E, Colao A, Longobardi S, Cardei S, Fazio S, Merola B, Lombardi G, Saccà L, Salvatore M. Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: Assessment with radionuclide angiography. Eur J Nucl Med 1996 23 : 390 394.
29. Maison P, Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: A meta-analysis. Circulation 2003 108 : 2648 2652.
30. Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D, Saccá L, Lombardi G. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993 77 : 1658 1661.
31. Tanriverdi F, Eryol NK, Atmaca H, Unluhizarci K, Ozdogru I, Sarikaya I, Bayram F, Kelestimur F. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. Clin Endocrinol 2005 62 : 706 712.
32. Leong KS, Mann P, Wallymahmed M, MacFarlane IA, Wilding JP. The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency. Clin Endocrinol 2001 54 : 819 826.
33. Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G. Impaired cardiac performance in elderly patients with growth hormone deficiency. J Clin Endocrinol Metab 1999 84 : 3950 3955.
34. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 1991 70 : 695 700.
35. Whitehead HM, Boreham C, Mcllrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin End 1992 36 : 45 52.
36. Williams SG, Barker D, Goldspink DF, Tan LB. A reappraisal of concepts in heart failure: Central role of cardiac power reserve. Arch Med Sci 2005 1 : 65 74.
37. Lang CC, Karlin P, Haythe J, Tsao L, Mancini DM. Peak cardiac power, measured non-invasively, is a powerful predictor of mortality in chronic heart failure. Circulation 2007 116 : II 505.
38. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM. Association between premature mortality and hypopituitarism. Lancet 2001 357 : 425 431.
39. Mukherjee A, Monson JP, Jonsson PJ, Trainer PJ, Shalet SM KIMS International Board. Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 2003 88 : 5865 5870.
40. Jakovljevic DG, Nunan D, Donovan G, Hodges LD, Sandercock GR, Brodie DA. Comparison of cardiac output determined by different rebreathing methods at rest and at peak exercise. Eur J Appl Physiol 2008 102 : 593 599.